1. Almirante B, Rodríguez D. Antifungal agents in neonates: issues and recommendations. Paediatr Drugs 2007;9:311–321.
2. De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs 2001;61:27–37.
3. Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van Rooy P, De Beule KL, et al. Effect of food on the pharmacokinetics of a new hydroxypropyl ß-cyclodextrin formulation of itraconazole. Pharmacotherapy 1996;16:424–428.
4. Marwaha RK, Maheshwari A. Systemic antifungal therapy in pediatric practice. Indian Pediatr 1999;36:1011–1021.
5. Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, et al. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual frame-work and analysis of in vitro–in vivo correlation data for fluconazole, itraconazole and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 1997;24:235–247.